Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Love this from Mac & Mike

Love this from Mac & Mike

posted on Sep 16, 2009 11:57AM

“This remarkable story demonstrates,” said Mac Leckrone, President of Alliacense, “that the reexam delay tactic routinely encouraged by lawyers defies business sense, since it usually backfires by strengthening the very patents under attack.”

Combined with favorable “Markman” Rulings in the Eastern District of Texas in 2007, and the steady addition of over 60 licensees since the launch of the Licensing Program in 2005, the MMP Portfolio™ continues its phenomenal ascendance as one of the most important patent portfolios in the history of electronics.

Mike Davis, Senior Vice President of Licensing, added “These developments obviously diminish any uncertainties associated with purchasing the required MMP Portfolio license, and will thus have a direct impact on the market price going forward.” Davis also confirmed that progressively higher royalty rates remain a basic principle of the MMP Portfolio Licensing Program.

Share
New Message
Please login to post a reply